


Senate Confirms Dr. Marty Makary and Dr. Jay Bhattacharya to Lead Health Agencies
The Senate confirms Dr. Marty Makary and Dr. Jay Bhattacharya to lead the FDA and NIH, respectively, amidst controversy over their COVID-19 responses.
Overview
Dr. Marty Makary and Dr. Jay Bhattacharya were confirmed by the Senate to lead the FDA and NIH, respectively, with votes of 56-44 and 53-47. Both nominees have previously criticized the federal government's response to COVID-19 and are seen as pivotal in shaping health policy under Health and Human Services Secretary Robert F. Kennedy Jr. Makary, from Johns Hopkins, has emphasized the need for fresh leadership at the FDA, while Bhattacharya, a Stanford professor, aims to restore public trust in health institutions. Their confirmation reflects a broader shift in health policy priorities aligned with the Trump administration's agenda.
Content generated by AI—learn more or report issue.

Get both sides in 5 minutes with our daily newsletter.
Analysis
- Marty Makary's confirmation as FDA commissioner was passed with bipartisan support, reflecting some Democratic backing despite concerns from their party.
- Makary must address contentious issues, including access to the abortion drug mifepristone and vaccine policy under a skeptical HHS Secretary.
- His previous criticisms of COVID-19 policies indicate he may favor reevaluating current practices at the FDA, while emphasizing the importance of vaccines.
Articles (3)
Center (1)
FAQ
Dr. Marty Makary has expressed skepticism about vaccine policies during the pandemic but did not commit to specific changes in his confirmation hearing. He mentioned reassessing vaccine-related meetings and emphasized a generational opportunity to address health issues with a focus on 'common sense' and science.
Dr. Jay Bhattacharya aims to decentralize NIH research and prioritize projects with direct benefits to American health, while also emphasizing transparency and reducing 'frivolous' research. He has advocated for a more inclusive environment that welcomes diverse viewpoints.
The confirmations of Dr. Makary and Dr. Bhattacharya align with the Trump administration's agenda by introducing more conservative health policies. Both nominees have been vocal critics of previous COVID-19 policies, promising changes in leadership and approach at the FDA and NIH.
History
- This story does not have any previous versions.